News

BioProcessOL
bioprocessonline.com > doc > automating-mass-spectrometry-analysis-to-accelerate-oligonucleotide-drug-development-0001

Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development

Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development2+ hour ago   (153+ words) Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development'Bioprocess Online Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development By Ada Yee, Scientific Communications This content is brought to you by Genedata, a Danaher Operating Company. Oligonucleotide therapeutics are reshaping…...

BioProcessOL
bioprocessonline.com > doc > new-ispe-framework-targets-uncertainty-in-pharma-s-ai-deployment-0001

New ISPE Framework Targets Uncertainty In Pharma's AI Deployment

New ISPE Framework Targets Uncertainty In Pharma's AI Deployment5+ day, 14+ hour ago   (402+ words) Guest Column | January 29, 2026 A conversation with Brandi Stockton and Martin Heitmann As artificial intelligence continues to find its way into regulated pharmaceutical operations, industry stakeholders have faced a persistent lack of consistent, practical guidance for deploying AI in GxP environments....